NCT03667313View on ClinicalTrials.gov

Treatment of In-Stent Restenosis 2 Study

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Coronary Restenosis
Interventions
COMBINATION_PRODUCT

sirolimus-eluting balloon (SEB) MagicTouch

Patients with coronary in-stent restenosis treated with sirolimus-eluting balloon

COMBINATION_PRODUCT

paclitaxel-eluting balloon (PEB) Sequent Please

Patients with coronary in-stent restenosis treated with paclitaxel-eluting balloon

Trial Locations (1)

70852

Cardiovascular Department of University Hospital, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT03667313 - Treatment of In-Stent Restenosis 2 Study | Biotech Hunter | Biotech Hunter